Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to ...
Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This ...
Combined healthy eating and exercise more effectively reduce harmful visceral fat, study showsWhen it comes to keeping that ...
Phase 1 Study in Non-Small Cell Lung Cancer Combined Reqorsa® Gene Therapy with Tagrisso® AUSTIN, Texas, Nov. 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the 'Company', 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data ...
Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in ...
Some tumors are almost impossible to treat. That's especially true for carcinomas, which don't behave like other malignancies. Some of these tumors ...
Visugromab combined with nivolumab showed a median duration of response exceeding two years in refractory NSCLC, UC, and HCC patients. GDF-15 is a therapeutic target and immune escape mechanism, ...
Presenters: Mark Erlander, PhD (CEO) Date: 12/02/2025 Time: 9:30 AM ET Interested parties can register for and access the live webcast for the conferences by visiting the “ Events ” section of the ...
A familiar hypertension drug is drawing new attention after researchers uncovered an unexpected connection to cancer science.